Picture of IRIDEX logo

IRIX IRIDEX Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for IRIDEX, fiscal year end - January 3rd, USD millions except per share, conversion factor applied.

2022
December 31st
2022
January 1st
2023
December 30th
2024
December 28th
2026
January 3rd
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-7.55-5.22-9.57-8.91-4.44
Depreciation
Non-Cash Items2.710.0762.582.414.18
Unusual Items
Other Non-Cash Items
Changes in Working Capital-5.1612.6-0.857-1.37-2.38
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-9.528.22-6.75-7.29-2.12
Capital Expenditures-0.286-0.213-0.109-0.013-0.143
Purchase of Fixed Assets
Other Investing Cash Flow Items0-5.34
Acquisition of Business
Sale of Fixed Assets
Cash from Investing Activities-0.286-5.56-0.109-0.013-0.143
Financing Cash Flow Items-0.094-0.629-0.087-0.551-0.075
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.0739.47-0.0052.65.96
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-9.9312.2-6.89-4.653.64